Are there any therapeutic applications targeting CD14?
Given its role in the immune response, CD14 has been explored as a potential therapeutic target. Strategies to modulate CD14 activity include the use of antibodies or small molecules that inhibit its interaction with LPS, aiming to reduce excessive inflammatory responses in conditions like sepsis. However, therapeutic applications targeting CD14 are still under investigation and require further research to establish their efficacy and safety.
